The e-clinical solutions market is estimated to account for USD X.X billion in 2017, and is projected to grow at a CAGR of X.X% to reach USD X.X billion by 2023. The market is majorly driven by the increasing count of clinical trials, rising number of government funding for such trials, growing need for improved data standardization, regulatory requirements associated with clinical research studies and increasing research and development of activities by pharmaceutical and biotechnology based companies. In addition, the adoption of global software solutions in clinical research studies, access data mounting from Healthcare industry and the presence of wide and strong range of products in the pipeline are another factors that boost the growth of this market.
However, the lack of awareness about the benefits of a clinical solution coupled with the infrastructure of these solutions are the prime factors hindering the growth of the market. Additionally, the lack of skilled professionals and high implementation cost associated with the e-clinical solution software also restricts the demand for e-clinical solutions. Moreover, the factors like growing clinical Research activities in developing region coupled with the outsourcing of clinical trial processes are expected to create more opportunities for this market. But, the software reliability issues and patient privacy concerns still serves to be the major challenges of e-clinical solutions market.
The e-clinical solutions market is segmented on the basis of product, type, delivery model, phase of clinical trials, end-users and region. On the basis of products, the market is fragmented into Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, Biostatistics and statistical programming solutions, Data conversion and standardization solutions, Electronic patient reported outcome solutions, e-clinical integration solutions, and Other e-clinical Solutions.
On the basis of types, the e-clinical solutions market is categorized into standalone and integrated systems. Whereas on the basis of delivery models, this market is fragmented into on-premises e-clinical solutions and on-demand or cloud-based e-clinical solutions. The on-demand e-clinical solution segment is growing at a faster rate, accounting to the increasing applications of internet of things, real time study management, adoption of standard and ad hoc reporting, etc.
On the basis of phase of clinical trials, this market is categorized into Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, and Phase IV Clinical Trials. Whereas, the end-user category comprises of pharmaceutical and bio-pharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, and hospitals. Among all, the pharmaceutical and bio-pharmaceutical companies is expected to dominate this market, owing to the increasing research and development activities for new product development, adoption of a centralized place to carry out all the trials related information and the improvement in clinical data management by the involvement of staff and data administrators.
Geographically, the market is segmented into North America, Europe, Asia and ROW. North America dominate this market, accounting to the elevating count of clinical trials, increasing research and development activities for the development of new product, supportive government policies and changing lifestyles. However, the Asian region is also reported to have a steady growth rate during the forecast years, owing to the increasing research and development activities in this region.
The key players operating in this industry are BioClinica, CRF Health, Datatrak International, Inc., Medidata Solution, Inc., Merge Health Incorporated, OmniComm Systems Inc., Oracle Corporation, and Parexel International Corporation.